ASRT
Price:
$23.5
Market Cap:
$151.86M
Assertio Holdings, Inc. is a specialized pharmaceutical company focused on developing and commercializing therapeutic solutions across key medical domains, including neurology, hospital care, and pain and inflammation management. Among its portfolio, Assertio offers INDOCIN, available as both an oral solution and a suppository. This medication addresses conditions such as moderate to severe rheumatoid arthritis (including acute flare-ups), ankylosing spondylitis, osteoarthritis, acute painful shoulder, and gouty arthritis. The company's offerings also encompass CAMBIA, an NSAID specifically formulated to alleviate symptoms associated with migraine headaches, including nausea, light sensitivi...[Read more]
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
1997-12-03
Stock Exchange
NASDAQ
Ticker
ASRT
According to Assertio Holdings, Inc.’s latest financial reports and current stock price. The company's current ROE is -38.72%. This represents a change of 249.35% compared to the average of -11.08% of the last 4 quarters.
The mean historical ROE of Assertio Holdings, Inc. over the last ten years is -74.79%. The current -38.72% ROE has changed -48.23% with respect to the historical average. Over the past ten years (40 quarters), ASRT's ROE was at its highest in in the March 2020 quarter at 49.06%. The ROE was at its lowest in in the December 2019 quarter at -332.35%.
Average
-74.79%
Median
-33.85%
Minimum
-374.76%
Maximum
48.57%
Discovering the peaks and valleys of Assertio Holdings, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 81.39%
Maximum Annual ROE = 48.57%
Minimum Annual Increase = -3982.76%
Minimum Annual ROE = -374.76%
| Year | ROE | Change |
|---|---|---|
| 2025 | -32.33% | 81.39% |
| 2024 | -17.82% | -92.59% |
| 2023 | -240.53% | -595.27% |
| 2022 | 48.57% | -3982.76% |
| 2021 | -1.25% | -97.53% |
| 2020 | -50.70% | -86.47% |
| 2019 | -374.76% | -2337.23% |
| 2018 | 16.75% | -127.70% |
| 2017 | -60.47% | 70.92% |
| 2016 | -35.38% | 47.16% |
The current ROE of Assertio Holdings, Inc. (ASRT) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-96.90%
5-year avg
-48.67%
10-year avg
-74.79%
Assertio Holdings, Inc.’s ROE is greater than InterCure Ltd. (-8.77%), greater than Nutriband Inc. (-112.60%), greater than XBiotech Inc. (-26.10%), less than Fortress Biotech, Inc. (163.88%), greater than Acrivon Therapeutics, Inc. Common Stock (-64.43%), greater than TScan Therapeutics, Inc. (-91.94%), greater than Pulmonx Corporation (-92.94%), less than Vaxart, Inc. (61.43%), greater than PMV Pharmaceuticals, Inc. (-68.98%), greater than Lite Strategy, Inc. (-90.81%),
| Company | ROE | Market cap |
|---|---|---|
| -8.77% | $53.08M | |
| -112.60% | $35.25M | |
| -26.10% | $70.43M | |
| 163.88% | $99.33M | |
| -64.43% | $49.54M | |
| -91.94% | $56.19M | |
| -92.94% | $54.06M | |
| 61.43% | $133.12M | |
| -68.98% | $60.26M | |
| -90.81% | $28.17M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Assertio Holdings, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Assertio Holdings, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Assertio Holdings, Inc.'s ROE?
How is the ROE calculated for Assertio Holdings, Inc. (ASRT)?
What is the highest ROE for Assertio Holdings, Inc. (ASRT)?
What is the 3-year average ROE for Assertio Holdings, Inc. (ASRT)?
What is the 5-year average ROE for Assertio Holdings, Inc. (ASRT)?
How does the current ROE for Assertio Holdings, Inc. (ASRT) compare to its historical average?